Skip to product information
L-Lysine 8 g / L-Proline 2 g Combo

L-Lysine 8 g / L-Proline 2 g Combo

Incl. VAT

Prescription

Dosage form: 50 ml infusion concentrate

Composition: L-lysine HCl, L-proline, citrate-phosphate buffer, water for injection

Prescription status: prescription only

Storage: store at room temperature

Shelf life: 1 year after manufacture

After completing your order, you will receive a link through which you can securely upload your prescription.

Anmeldung erforderlich
PRODUCT INFORMATION

Composition:

  • L-Lysine HCl 8000 mg 
  • L-Proline 2000 mg 
  • Citric acid phosphate buffer 
  • Water for injection up to 50 ml 

Administration: i.v., always prepare the infusion solution freshly dilute as a single infusion in 100ml 0.9% NaCl 

Infusion set: Intrafix © Air P 

Duration of infusion: 30 minutes 

Therapy interval: 1-2 times per week, based on the patient's health status 

Duration of treatment: 8 weeks, based on the patient's health status 

Storage: 15 – 25°C 

Shelf life: 1 year after manufacture

Side effects: not known 

THERAPY RECOMMENDATION

Positive Effects:

  • L-Lysine is an essential amino acid.
  • L-Proline is a non-essential amino acid.
  • For further information, please refer to the mono-infusions.

Tip: For infections, combine with 15 g Vitamin C

Therapy recommendations: There are indications that the properties of the substances contained in the product may have a positive effect on health disorders of the mentioned indications:

  • Improved wound healing
  • Higher elasticity and firmness of the skin
  • Herpes infections such as EBV, shingles, herpes simplex, CMV: therapeutic and for prevention in recurrent infections
  • Pain therapy for chronic degenerative pain conditions, osteoarthritis, osteochondrosis, slipped disc problems
  • In cases of accidents and bone fractures: support for strengthening cartilage, bones, muscles, and tendons
  • Atherosclerosis, the deposition of lipoprotein (a) is prevented
  • Hypercholesterolemia: support of LDL lipid metabolism
  • Diabetes mellitus type 2 and insulin resistance
  • In cases of connective tissue-related venous insufficiency
  • Anti-inflammatory effect

Contraindications:Do not use in children under 6 years of age. In cases of impaired kidney, liver, or heart function, and in cases of albumin deficiency, an adjustment of the individual dose is recommended. Patients taking beta-blockers have an increased risk of a decompensated cardiovascular reaction, as beta-blockers inhibit the effect of adrenaline (emergency medical treatment). Patients with a tendency to allergic reactions and/or with diseases based on histamine release (e.g., asthma) should be questioned about known allergens in accordance with the principles of therapeutic due diligence.

Note for doctors and therapists: In individual prescriptions, the doctor/therapist fundamentally determines the indication. The suggestion is merely a recommendation for a therapy option, with the dosage and frequency of application being solely at the discretion of the doctor/therapist. The treating therapist is responsible for the treatment and must individually check and assess the respective application for each patient before starting treatment.

Shipping Information

NATIONAL:

  • Standard shipping: €9.95 incl. VAT
  • Free shipping on orders over €200.00 (does not apply to refrigerated goods and express shipments)
  • Refrigerated and express shipping: €25.95 incl. VAT

Note: If individual products are unavailable, partial deliveries may occur, incurring no additional shipping costs.
Any requested partial deliveries will be charged.

WITHIN THE EU:
For shipments to countries in EU Zone 1, we charge logistics costs of €75.00 (incl. VAT).

For shipments to countries in EU Zone 2, we charge logistics costs of €105.00 (incl. VAT).

THIRD COUNTRIES:
The customer is asked to inquire about the logistics costs incurred for the respective country.

References

We have researched the literature references with the greatest possible care. Nevertheless, we assume no liability for the completeness and up-to-date nature of the study information. Many of the therapy options mentioned in the product information are based on findings obtained from animal or human cell cultures, animal experiments, observational studies, and to a lesser extent, randomized controlled trials (RCTs).
The study situation regarding complementary medicines is subject to continuous development, which can sometimes lead to different results. We therefore recommend that therapists always carefully review the current study situation before using such preparations.

1) Gröber, U. 2008. Orthomolecular Medicine. A Guide for Pharmacists and Physicians

2) Gröber U. Micronutrients – Metabolic Tuning-Prevention-Therapy. Wissenschaftliche Verlagsgesellschaft, Stuttgart 2010

3) Schmidbauer C, Hofstätter G. Micronutrient Coach – The Great BIOGENA Compendium of Nutrients. Verlagshaus der Ärzte, 2018

4) Shelbi L Christgen, Donald F Becker, Role of Proline in Pathogen and Host Interactions, Antioxid Redox Signal, 2019, 30(4):683-70